FORM SC 13G

Company

CERO THERAPEUTICS HOLDINGS, INC.

Filed

May 6, 2022

Accession Number

0001062993-22-011796

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →